Antihyperthermic treatment decreases perihematomal hypodensity

Neurology. 2020 Apr 21;94(16):e1738-e1748. doi: 10.1212/WNL.0000000000009288. Epub 2020 Mar 27.

Abstract

Objective: To investigate the effect on perihematomal hypodensity and outcome of a decrease in body temperature in the first 24 hours in patients with intracerebral hemorrhage (ICH).

Methods: In this retrospective study on a prospectively registered database, among the 1,100 patients, 795 met all the inclusion criteria. Temperature variations in the first 24 hours and perihematomal hypodensity (PHHD) were recorded. Patients ≥37.5°C were treated with antihyperthermic drugs for at least 48 hours. The main objective was to determine the association among temperature variation, PHHD, and outcome at 3 months.

Results: The decrease in temperature in the first 24 hours increased the possibility of good outcome 11-fold. Temperature decrease, lower PHHD volume, and a good outcome were observed in 31.8% of the patients who received antihyperthermic treatment.

Conclusion: The administration of early antihyperthermic treatment in patients with spontaneous ICH with a basal axillary temperature ≥37.5°C resulted in good outcome in a third of the treated patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / therapeutic use
  • Aged
  • Aged, 80 and over
  • Antipyretics / therapeutic use*
  • Body Temperature
  • Cerebral Hemorrhage / complications
  • Cerebral Hemorrhage / diagnostic imaging*
  • Cerebral Hemorrhage / physiopathology
  • Cerebral Hemorrhage / therapy
  • Dipyrone / therapeutic use
  • Female
  • Fever / drug therapy*
  • Fever / etiology
  • Hematoma / diagnostic imaging*
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies

Substances

  • Antipyretics
  • Acetaminophen
  • Dipyrone